The Cure Starts Now has funded $25,084,877 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 163 grants at over 100 hospitals in 29 countries.




UNC Eshelman School of Pharmacy – $50,000

Amount
$50,000.00
Date
December 2024

Leveraging Open Science and Collaboration to Identify Clinical Quality ALK2 Inhibitors for DIPG

Murdoch Children's Research Institute – $100,000 USD / $156,914 AUD

Amount
$100,000.00
Date
December 2024

Harnessing Developmental Neurobiology to Reprogram the Cell of Origin of Diffuse Midline Gliomas

Children's Healthcare of Atlanta – $100,000

Amount
$100,000.00
Date
November 2024

Radiation Resistance in Medulloblastoma

University of Texas Health Science Center at San Antonio – $100,000

Amount
$100,000.00
Date
November 2024

Targeting Metabolic Vulnerabilities for Treating Medulloblastoma

University of Texas Health Science Center at San Antonio – $50,000

Amount
$50,000.00
Date
November 2024

Targeting RRNA Modification and SNORNA Function, A Novel Concept to Treat Aggressive Medulloblastoma

Children’s National Medical Center – $300,000

Amount
$300,000.00
Date
November 2024

Multilamellar H3K27M RNA aggregates targeting diffuse midline glioma, including diffuse intrinsic pontine glioma.

Children's Hospital Los Angeles – $100,000

Amount
$100,000.00
Date
October 2024

Targeting FOXR2 in Diffuse Midline Gliomas

University Hospital of Navarra - $100,000 USD, €92,637 EUR

Amount
$100,000.00
Date
October 2024

Targeting Diffuse Midline Glioma vulnerabilities as a therapeutic strategy.

The Institute of Cancer Research – $111,445 USD / £85,976 GBP

Amount
$111,445.00
Date
October 2024

Unravelling transcriptional plasticity as a non-genetic mechanism of drug resistance in DMG.

Children’s Cancer Institute – $100,000 USD / $150,589 AUD

Amount
$100,000.00
Date
October 2024

Targeting lactate production pathways as a novel therapy against DIPG

Sydney Children's Hospital - Randwick – $196,577 USD / $296,025.11 AUD

Amount
$196,577.00
Date
October 2024

Unlocking the potential of the blood-brain barrier in the fight against paediatric brain gliomas.

McGill University - $100,000

Amount
$100,000.00
Date
October 2024

Understanding tumor heterogeneity and characterizing treatment responses in ACVR1-mutated diffuse midline gliomas.

Cincinnati Children’s Hospital Medical Center - $200,000

Amount
$200,000.00
Date
October 2024

Combining FLASH and immunotherapy to target medulloblastoma relapse

Emory University / Cincinnati Children's Hospital – $93,250

Amount
$93,250.00
Date
March 2024

SUMOylation as a novel therapeutic target in DIPG

University of Chicago Medical Center / Washington University St. Louis – $100,000

Amount
$100,000.00
Date
December 2023

Characterizing and Targeting ABL1 and ABL2 in Medulloblastoma Leptomeningeal Dissemination.